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INTRODUCTION

Epilepsy affects at least fifteen million people in the world
today.

Early descriptions of epileptic seizures date from 2000 B.C.

The most widely accepted general definition of epilepsy was proposed
almost a century ago by Hughlings Jackson, who proposed that seizures
were caused by an "occasional, sudden, excessive, rapid and local
discharge of grey matter" which spread from an abnormal focus to normal
brain tissue (Jackson, 1931)-

Introduction of the electroencephalogram

(EEG) in the early 1930s was a significant development enabling scien
tists to describe precisely and evaluate different types of epilepsy.
There are many ways to classify epilepsy.

The following classification

has been chosen to best typify types for this paper.
The first classification of epilepsy is focal epilepsy, where a
seizure originates in a local area of grey matter, and convulsions may
be confined to a single limb or muscle group.

This type of epilepsy

might develop after a head injury or abscess resulting in pressure of
scar tissue forming on the cortex of the brain.

If the patient is

conscious, an aura or sensation may occur which can help in localizing
the origin of the epileptic discharge.

Usually, focal epilepsy is

considered to consist of seizures originating in the cerebral cortex,
and not in underlying structures.

Electrically, in focal epilepsy,

there are usually interictal discharges present which can be detected
with an EEG in the period between overt seizures.

Focal epilepsy may or

may not develop into a generalized convulsive or grand mal seizure.
The second major type of epilepsy is characterized by petit mal

1
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(absence) seizures.

These brief generalized seizures usually occur in

children between eight and fourteen years.
discharges in this class.

There are no interictal

The overt seizure is usually limited to

abrupt loss of consciousness which is rapidly regained, usually in five
to ninety seconds.

This type of epilepsy is suspected when no cortical

focus can be detected.

The three per second spike and wave abnormal

discharge seems to originate in the brain stem and subsequently spreads
to both cerebral hemispheres.

Changes in body chemistry such as hyper

ventilation may initiate a petit mal seizure.

Drugs effective here may

not be effective in any other type of epilepsy.
The third category of epilepsy is generalized tonic-clonic or grand
mal.

This class includes Jacksonian epilepsy which is characterized by

seizures originally local in nature which subsequently spread to the
entire brain.

This is a less distinctive class which may be initiated

by generalized biochemical or metabolic disturbance in the brain such as
in progressive degenerative diseases of the brain.

Deep brain struc

tures as well as the cortex are involved. The conclusions are major,
usually with tonic spasm of all muscles followed by synchronous clonic
jerking and prolonged depression of all central functions.

Unlike focal

epilepsy, there are multiple areas of susceptibility to seizures in
volving large areas of both hemispheres, or sometimes the entire brain.
Status epilepticus is a series of rapidly repeated epileptic convulsions
without any periods of consciousness in between.

The EEG shows diffuse

continuous spiking.
The science of understanding and treating the disease of epilepsy
was greatly advanced by the acceptance of the use of animal models for

with p erm ission o f the copyright ow ner. Further reproduction prohibited w ithout p erm ission.

research.

Intravenous injections of certain drugs or various forms of

cortical insult create, in laboratory animals, a variety of symptoms
which behaviorally, morphologically, or electrophysiologically appear
similar to characteristic seizure phenomena in man. In the present study
an experimental model of chronic focal epilepsy was created by placing a
tiny piece of cobalt metal on the surface of one hemisphere of the
cerebral cortex of rats.
The presence of the cobalt metal, by some mechanism not well under
stood, promotes development of spontaneously epileptic nervous tissue in
the area of the implant.

The abnormal, but discrete, section of the

cortex from which random bursts of electrical discharge originate, is a
chronic epileptogenic focus.

Following implantation, the electrical

activity of the cortical area adjacent to the site of implant, and of
the corresponding area of the opposite undisturbed cerebral hemisphere,
was recorded with cortical electrodes.

The progressive development of

the epileptogenic focus with certain cortical neurons discharging in a
random, irregular manner with abnormally high bursts of electrical
activity was monitored.

Once the presence of the focus had been es

tablished, four drugs commonly used in the treatment of epilepsy in
humans were selected and their effect on the electrical activity of the
brain was observed.
There were four major objectives of this study.
observe any physiological change in the brain tissue.

The first was to
This was measured

electro-physiologically with an electroencephalogram (EEG), and re
cordings were made from forty-eight hours to 178 days after implantation
of the cobalt.
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The second objective was to watch for the spread and development of
a secondary focus on the "mirror" side or undisturbed cerebral hemis
phere of the brain.

A secondary focus would be indicated by abnormal

spontaneous electrical discharges originating on the undisturbed side of
the brain, or areas of abnormal morphology in the appearance of the
cerebral cortex in sections of the undisturbed hemisphere.
The third objective was to observe the effect of four anticonvul
sant drugs, diazepam, phenobarbital, phenytoin, and trimethadione, on
the electrophysiological state of the primary focus.

The electroen

cephalogram was recorded before and after drug administration, and any
changes were recorded.
The final or fourth objective was a morphological study of the
lesions.

The affected areas of the brain were removed and appropriate

histological and histochemical stains were used to compare the structure
and composition of the epileptogenic tissue to that of control animals.
The changes in the tissue over a period of time from eleven days to 178
days were observed.
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LITERATURE REVIEW

Focal Models of Epilepsy-

Various techniques for the development of a model of epilepsy have
been studied.

While many of these methods are useful in simulating

behavioral and electrical events in epilepsy, the entire brain is in
volved, the seizure is of a short duration and, unlike clinical epi
lepsy, does not recur.
Chronic models have been developed to aid in the study of the
mechanism by which damaged or diseased neurons generate spontaneous
chronic clinical epilepsy.

These models of epilepsy are created by

damaging or irritating a portion of the brain tissue.

Also, repetitive

bursts of photo simulation, ten to fifteen hertz, are used for induction
of seizure in animals that have a lower convulsive threshold than normal
animals, e.g. animals with experimentally produced epilepsy.

The epi

leptic models produced in these animals are similar to behavioral and
electrical r.anifestations of clinical

epilepsy in man.

Furthermore,

there is convincing evidence that makes the further utilization of these
models valuable as a tool for research. A review of these models can be
found in Ward, 1969.
Implantation of heavy metals on the cortex of the brain to produce
experimental epilepsy, has been extensively studied.

The most success

ful model has been created by the implantation of cobalt powder or wire,
and will therefore be the only model reviewed here. The cobalt model of
experimental epilepsy is not well understood. Spontaneous generalized
5
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convulsive attacks are rare, but animals implanted with this heavy metal
become sensitive to sub-threshold convulsive stimuli which would not
affect normal animals.

On the fourth or fifth day after implantation on

the cortical surface, seizure activity can be monitored with an electro
encephalogram, but usually no clinical or behavioral seizures are evi
dent (Henjyoyi and Dow, 1965). A delay between cortical insult and
initiation of spiking was observed, but any behavioral event such as a
muscle or whisker twitch always occurred simultaneously with a spike in
the EEG.

The seizure threshold, tested by electroshock and Metrazol

(pentylenetetrazol) challenge, were lower in cobalt implanted animals.
Prodding or stressful handling did not produce clinical (behavioral) or
electrical seizures.

Spontaneous electrical seizures were observed,

however, and strong independent focal spike activity was observed on
both sides of the brain after eight days (Kopeloff, 1960).

Anatom

ically, large lesions were present in all rats within one week after
cobalt implant, but the size of the lesions did not correspond to the
amount of primary electrical activity (Engel, 1968).
the rats was normal at all times.

The behavior of

Rats, implanted in the frontal lobe,

developed spiking on the mirror side of the brain before the primary
side, after which spikes were recorded from the primary side (Dow et
al., 1972). In the parietal lobe, any signs of focus development con
sistently disappeared, whereas the abnormal activity in the frontal lobe
lasted three to nine months after implantation.

Morphology of the Cobalt Lesion

Kopeloff (1960) reported that several heavy metals, in particular
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cobalt, had epileptogenic properties when applied to the brain of rats
and mice.

Payan (1967) implanted several cats with copper, brass, and

silver metals, and observed mild gliosis, but no lowered epileptic
convulsive threshold, or chronic epileptic focus.

Cobalt, both in

powder and solid form, produced edema, congestion, inflammatory re
sponse, fibrous tissue reaction around the lesion, gliosis, neuronal
damage, iron and calcium deposits, scarring of the meninges and an
increased presence in many subacute inflammatory cells.

Inflammatory

infiltrates were more diffuse in powder-implanted rats.

The crater in

the brain of rats implanted with a metallic sliver of cobalt, was more
effectively localized by formation of a fibroglial scar.

The crater

left by the cobalt powder was filled with cell debris and inflammatory
cells, whereas the crater formed by the cobalt rod was virtually empty
(Engel, 1968).
Although other metals caused necrosis without lowering the con
vulsive threshold, the severe vascularity and the calcium deposit may
have been involved in the mechanism by which the convulsive threshold
was lowered.

Heavy metals are thought to exhibit convulsant action

because of interference with enzymatic processes of the cell rather than
by mechanical effect of its presence, or the secondary scarring which
follows.

Dow et al. (1972) concluded that epileptic activity can not

be related to the scar or reactive gliosis.

Epileptic activity some

times decreases one to two weeks after implant, when the reaction is
strong, but no scar is formed.
Dow et al. (1972) reported that the implantation of solid cobalt
made a discrete lesion, and that the contralateral hemisphere was always
normal.

The cobalt lesion was two to three millimeters in diameter, and
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was necrotic with varying degrees of fibrosis.

The central lesion area

was surrounded by a layer of calcium deposit and gliosis.

The adjacent

brain tissue had increased vascularity with neuronal degeneration.

A

slight pial thickening was observed at the site of each screw electrode
on the brain, probably due to pressure from the screws on the brain.
Glass implants produced no necrotic reaction or any evidence of abnormal
electrical activity.

Dow et al. (1962) suggested that the epileptic

activity probably depends on cobalt's chemical influence on the neurons
of the cortex which at first shrink then disappear.
examined the epileptogenic effect of cobalt.

Payan in 1967

He found that cobalt

slivers worked as well as cobalt powder, and therefore, the effective
ness could not be related to the solubility of the powder, furthermore,
cobaltous nitrate, a soluble powder was not effective.

A breakdown of

the blood brain barrier was not involved, because other metallic im
plants of the same size and shape and in the same location did not lower
pharmo-convulsive thresholds.

The epileptic foci were not caused by the

necrotizing effect, gliosis, or fibrosis because other metals and com
pounds produced similar histological response without epileptic activ
ity.

Payan concluded that severe vascularity around lesions and heavy

calcium deposits, or some inherent power or molecular conformation of
the cobalt could possibly initiate the epileptogenic state.
Cesa-Bianchi et al.

(1967) applied cobalt powder to the cortex of

50 cats and observed that nerve cells involved in the lesion were
modified in structure with less stainable nissl zones.
reaction was much more severe after three to four weeks.

The glial
Electroclin-

ical manifestations induced by powder faded away as the perifocal glial
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reaction became more intense.

This suggested that the epileptogenic

effect is due to direct action of powder on neurons located at the
implant site.

He suggested that alteration of cellular oxidative

processes may cause a direct massive, and abnormally excitatory action
on nerve cells in the lesion site.

Payan et al. (1965) found that rats

with extradural or extracranial cobalt implants were epileptic, but had
only meningeal adhesions, local depressions of the cortical surface,
minimal subadjacent necrosis, and granulation of tissues.

He therefore

concluded that cobalt epilepsy can be produced without concurrent
severe necrosis.
Fischer et al. (1968), observed that scarring and EEG abnormalities
occurred at the same time.

In animals with strong inflammatory reaction

or abscess, no epileptic activity could be found in the EEG.

Engle

(1968) found that six days after cobalt implantation the primary epi
leptic focus was poorly developed, whereas after eight days, it was well
developed with dependent mirror focus activity.

Eleven days after

cobalt implantation, the rat cortex was electrically depressed and no
epileptiform activity appeared to propagate from the mirror focus to
the primary site.

The primary focus in the powdered cobalt rat devel

oped on the anterior edge of a large lesion, several millimeters an
terior to the implant.

By day 18, the cobalt implanted rat had spike

activity several millimeters anterior the site of implantation and a
mirror focus homotopic and contralateral to the primary focus rather
than to the site of implantation.
18.

The primary focus was active at day

At day 24 the focus activity was depressed, and Engle found that

the primary focus activity was absent by the thirty-second day after
implant.

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited without p erm ission.

10

There are several excellent histological descriptions (Payan, 1971;
Dow et al., 1962; Cesa-Bianchi et al., 1967; Fischer et al., 1968; and
Henjyoyi and Dow, 1965) of the development of the epileptogenic lesion
in the brain of rats.

These reviews are briefly combined here to give

an overview of the morphological aspects of cobalt implantation of the
cortex of the brain.
During the first through third days after implantation, Payan
(1971), described edema, congestion, necrosis in rats implanted with
cobalt.

Eight hours after implant, there was minimal edema or necrosis

around the lesion, and the tissue adjacent to the lesion showed vacuolar
degeneration with a few anoxic neurons.
and blood vessels appeared normal.

There was little demyelination

From one to six days after implant,

Payan (1971) and Cesa-Bianchi et al. (1967) saw a similar picture with
gradual exaggeration of the tissue response.
ually increased.

Size of the lesion grad

Edema and necrosis increased, minimal hemorrhage was

noted, and spongy degeneration was more extensive.

Anoxia and neuronal

degeneration was seen around the lesion with moderate proliferation of
astrocytes and blood vessels and fibroblasts.

Bodian, cresyl violet and

silver stained tissue, showed granular substance adjacent to the necro
tic center of the lesion.

Some distortion and disruption of axons were

noted, and the number of cells in the adjacent cortex was reduced.
Between the first and second week after implant, Henjyoyi and Dow,
1965, found inflammatory and phagocytic cells at the borders of the
lesion. Payan (1971) and Dow et al. (1972) observed an exaggeration of
most of the tissue responses seen in the first week after cobalt im
plantation in rats.

A calcium deposit gradually appeared around the

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited w ithout p erm ission.

11

lesion within the granular area and became more intense with time.
Occasional small necrotic foci were noted a few millimeters away from
the main lesion with granules near the center similar to those found in
the main lesion.
Cesa-Bianchi et al.

(1967) found that the glial reaction was more

pronounced when the animal was sacrificed three to four weeks after the
implant.

Nerve cells involved were modified in structure with less

stainable nissl zones.

Henjyoyi and Dow (1965) found a fibrous menin-

gocerebral scar at the site of the cobalt implant.

Payan (1971) ob

served a marked proliferation of fibroblasts, histiocytes, astrocytes
and blood vessels.

The intensity of the edema and vacuolar degeneration

was reduced from the third week to the sixth.

The fibroblastic and

histiocytic reaction was prominent with an occasional giant cell.

The

calcium deposit was heavier, and a minimal iron deposit was noticed in
some animals.

Pronounced proliferation of blood vessels and a reticular

network was still seen adjacent to the lesion in some sections stained
by the reticular and Bodian methods.

Meninges showed severe fibrosis.

Some studies showed perivascular lymphocytic cuffing a few millimeters
from the primary lesion.

On the sixteenth day, Dow et al. (1962) found

that the reaction totally surrounded the lesion and the lesion was
increased in size, deepened and more circular.

The center was pale and

the outer part deeply stained because of striking cellular infiltration.
One to three months after cobalt implant in rats, Payan (1971)
reported that the tissue reaction had lessened after a few months,
whereas the calcium deposit and the blood vessel proliferation increased.
Some animals again showed perivascular cuffing and psammona bodies
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(small brain tumors with calcareous particles).

Vacuolar degeneration

of the cortical lesions occurred from seven to ten weeks after implant,
with occasional neurons calcifying around the main lesion.

The fibro

blastic and histiocytic reaction was still active, although myelin was
not affected.

The surrounding tissue was vascular with occasional

distant lesions characterized by calcification and necrotic areas.

A

few animals showed lateral ventricle dilation on the same side as the
implant.

No direct connection between the cobalt lesion and the dilated

ventricle was hypothesized.

After two months, Dow et al. (1962) noticed

the lesion was larger, and an inflammatory reaction extended from periph
eral parts of the lesion into the central area.
Three to six months after implant, Payan (1971) reported reactions
similar to those described previously, with moderate rather than severe
intensity.

Exceptions were the calcium deposit and the vascular pro

liferation which were quite intense.
the lesion.

The calcium completely engulfed

After six to twelve months, Dow et al. (1962) observed that

the central core of the lesion had disappeared, but there was a dense
sclerotic reaction surrounding the site of the cobalt application.
Payan (1971) noted a decreasing intensity of the inflammatory processes,
but the heavy calcium deposit actually interfered with sectioning of the
tissue.

Many animals had a solid band of calcium around the lesion.

Vascularity of adjacent brain tissue was intense, but all other reac
tions were markedly reduced.

Twelve months after implant Payan (1971)

reported that some of the rats were still epileptic.
Fischer et al., in 1968, published an excellent review of zone
histology, describing the development of the lesion as changes occurred
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in the layers or zones of brain tissue below the surface of the cortex.
Electron microscopic studies of epileptic lesions are presented in a
paper by Westrum et al. (1964).

Secondary Epileptogenic Lesions

There is much controversy surrounding the appearance and physiology
of secondary epileptogenic lesions.

Guerrero-Figueroa et al. (1964)

described the secondary lesion as a ganglionic network in which spon
taneous and evoked activity have been chronically altered by continous
epileptiform bombardment, causing a lasting metabolic aberration to take
place in the cells at the secondary site.

These authors, in contrast to

others, reported that no structural change took place at the secondary
site.
Morrell et al.

(1959), using a method of topical freezing with

ethyl chloride, observed that there was always an anatomical connection
between the primary and secondary foci.

This connection was at least

one synapse away, and appeared to be callosally mediated. The secondary
spike was always an evoked potential at first, and later became inde
pendent.

Payan (1970) observed that the secondary or mirror focus takes

over when the primary focus has been surgically removed, and has inde
pendent activity.

Ischemia on one or both sides of the brain increased

the convulsive threshold by the same amount. Engle (1968) agreed that
the secondary epileptogenesis observed in rats appeared similar to the
mirror focus described in other animals. Dense cells arranged in dis
crete nests were seen in the contralateral cortex of epileptic rats, and
these corresponded topographically to the borders of the primary lesion.
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These nests contained darkly stained fibrillar neurons.

The basophilic

properties of the cells with their densely stained dendrites resembled
mirror epileptic cortex, as described by Morrell et al. (1959).

Similar

basophilic neurons were observed in control animals but throughout the
entire cortex* whereas the secondary epileptogenic cortex contained
discrete nests which were either anterior, posterior, medial or lateral
to points homotropic and contralateral to the original site of implant.
Morrell, 1969, found that the secondary focus could be readily
identified by the nests of pyronine-dense cells, stained with methyl
green pyronine, aqueous azure B bromide, or gallocyanin at acid pH.

The

secondary focus was thirty-five to fifty percent increased over controls
in azure B binding. This basophilic substance was RNA. Increased dye
binding was limited to neurons and the glia were not altered.

Jasper

discussed three possible hypotheses concerning the presence of an in
creased RNA concentration in the secondary focus site.

The first

hypothesis assumed that the cells might be dying or dehydrated
and the increased RNA concentration was a function of decreased cell
size rather than increased RNA concentration.

Perhaps the continuous

bombardment from the primary focus across the callosal pathways
was sufficient to cause damage and eventual death of the neurons in the
mirror focus.
be inactive.

The second hypothesis suggests that the dense cells might
Studies were reported suggesting that physiological inhib

ition of activity on a neuron would cause decreased RNA consumption and
result in dense chromophilic cells due to accumulation of this substance
intracellularly.

The third hypothesis suggested that the hypersynchrony

and rapid unit discharge could result from intracellular alterations in
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RNA.

Unfolding the RNA molecule would result in total increase in

closely spaced atomic charges.

Potassium concentration near the mem

brane would change and an increase in the intracellular potassium would
occur, resulting in hyperpolarization.

This would make the neuron less

responsive until specific synchronizing input from the primary foci or
some other source was received.

Anticonvulsant Drugs

There are three mechanisms by which anticonvulsant drugs might
affect seizures (Goodman and Gilman, 1975).

First is an effect on non

neuronal lesions, such as normalization of the ischemic blood supply of
typical cortical seizure foci.

The second exerts effects confined to

pathologically altered neurons of the seizure focus, to prevent their
excessive discharge.

The third category of anticonvulsant drugs affects

normal neurons to prevent their discharge by the seizure focus.

Dow et

al. (1973) suggested that most antiepileptic drugs in current clinical
use probably exert their effect on normal neurons by preventing spread
of depolarization from the seizure focus.

The ideal anticonvulsant

would have effects confined to abnormal neurons of the focus to prevent
excessive discharge.

This ideal anticonvulsant drug would not neces

sarily show potent anticonvulsant activity in the standard laboratory
animal tests where no chronic pathological state exists. Electroshock
and administration of convulsive drugs like Metrazol, are examples of
commonly used models of seizure activity which produce no chronically
altered or damaged neurons.

Swinyard (1969) proposed that drugs which

modify electrically and chemically induced generalized seizures, and
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raise the seizure threshold for low-frequency electroshock in animals
are those which are clinically effective against grand mal seizures.
Boyer (1966) had three theories for forecasting clinical drug useful
ness.

The first, similar to that of Swinyard, was that drugs which

block seizures induced by maximal electroshock should be effective
against grand mal in man.

Secondly, those which inhibit minimal e-

lectroshock might benefit patients with psychomotor seizures.

Lastly,

protection against Metrazol-induced seizures will be seen with drugs
which are clinically effective against petit mal epilepsy.
Four anticonvulsant drugs, representative of four major types of
anticonvulsants in common clinical use, were tested in this study. The
first drug studied was diazepam (Valium).

This drug is characteristic

of a group of drugs called the benzodiazepines.

These were first in

troduced as tranquilizing agents, and possess varying degrees of anti
convulsant action against grand mal, petit mal, and psychomotor epilepsy
(Boyer, 1966).

Diazepam is surprisingly nontoxic and large single doses

calm patients.

Therapeutic doses cause a low voltage, fast activity EEG

tracing lasting a week after the drug is discontinued in humans (Boyer,
1966).

Bell (1970) observed that the effect of diazepam on the EEG

resembles that of rapidly acting barbiturates.

An intravenous dose

large enough to impair consciousness generates activity similar to
barbiturate fast activity, within two minutes.

In status epilepticus

seizure discharge is reduced or gone (Bell, 1970).
In experimental models of epilepsy, benzodiazepines suppress the
spread of seizure activity produced by epileptogenic foci in the cortex
but do not abolish the abnormal discharge of the focus (Goodman and
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Gilman, 1975). Van Duijn and Visser (1972) using cobalt-powder implanted
cat brains, found that diazepam increased the amount of focal EEG epi
leptic activity.

Stark et al. (1974) concluded that diazepam 0.5 mg/kg

and 1 mg/kg was anticonvulsant in cats with penicillin-induced foci.
Randall et al. (1961), and Spehlmann and Colley (1968), agreed that
unmistakable protection against chemical shock and maximal electroshock
was observed, but an unequivocal effect on focal epilepsy has not been
demonstrated (Guerreo-Figueroa et al. , 1968 and Spehlmann and Colley,
1968).
Phenobarbital (Luminal), the second drug studied here, was the
first effective organic antiepileptic agent (Hauptman, 1912).

Pheno

barbital has been found to be clinically effective in treatment of
generalized tonic-clonic (grand mal) and cortical focal seizures and in
status epilepticus.

Its effects are very general and nonspecific

compared to phenytoin and trimethadione.

Phenobarbital has more side

effects and is slower acting than diazepam.

Phenobarbital limits spread

of seizure activity and also elevates seizure threshold (Goodman and
Gilman, 1975).

Phenobarbital is often the first medication tried for

grand mal and focal seizures (Woodbury et al., 1972) but is not ef
fective in temporal lobe epilepsy, and may actually make petit mal
seizures worse.

Sedation is common in initial treatments, but this

disappears after continued use.

Phenobarbital possesses a significant

antiepileptic effect at dose levels that do not cause sedation.

Abrupt

withdrawal may increase seizure frequency or precipitate status epi
lepticus.
Dow et al. (1973) demonstrated that phenobarbital given acutely to
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cobalt-epileptic rats increased EEG spiking, while phenytoin given
acutely or chronically had no abnormal effect on spiking activity.

Van

Duijn and Visser (1972) found no significant effect on the EEG in cats
implanted with cobalt powder, which were treated with phenobarbital.
There is a threshold raising effect for chemical shock and electroshock.
Some experimenters assume it suppresses focal cortical epileptic dis
charges (Millichap, 1969), whereas others observed activation of the
focus (Morrell et al., 1959).

Roldan et al. (1971) found that in

cobalt implanted rats, the presence of sleep cycles after the low dose
make measurement of duration of effect difficult.

Spikes around the

focus increased after barbiturate administration and during slow wave
sleep.

Low doses depressed spontaneous seven to nine per second spike

bursts, ten to fifteen minutes after injections.

High doses of barbi

turates suppressed spike and spike bursts for several hours.

Guerreo-

Figueroa et al. (1964) found that phenobarbital inhibited development of
a secondary focus.

Rats receiving fifty milligrams phenobarbital daily,

beginning seven days after implantation of alumina, did not develop a
secondary focus until three weeks after drug discontinuation.

Daily

administration of fifty milligrams phenobarbital, begun three months
after alumina implantation, suppressed or reduced the frequency of
clinical convulsive seizures, and the previously established primary and
secondary foci were diminished in amplitude and frequency of discharge.
Therefore, it appears that phenobarbital retards the establishment of
secondary epileptiform discharges but has little effect on the primary
focus.
Another drug tested was phenytoin, also known as diphenylhydantoin
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(Dilantin) which is of the hydantoin family and is a primary drug for
all types of epilepsy except petit mal.

Of the four drugs tested, Boyer

(1966) found phenytoin to be less effective than diazepam, trimethadione
or phenobarbital, in elevation of threshold for seizures produced by
convulsant drugs like Metrazol but was second only to diazepam in pro
tection against maximal electroshock-

Phenytoin was less effective than

phenobarbital or diazepam against minimal electroshock, but better than
trimethadione.

Unlike phenobarbital, phenytoin is effective against

temporal lobe epilepsy.

Van Duijn and Visser (1972) found phenytoin

suppressed electrocortical focal epileptogenic activity in cats with
cobalt foci.

In rat studies conducted by Guerrero-Pigueroa et al.

(1964), phenytoin was given one week before alumina implant, and three
weeks after.
istic EEG.

The primary and secondary foci developed with character
Ten mg/kg intraperitoneally daily resulted in no inhibition

of the EEG but a toxic effect was observed.
tures, spindles were observed,
high amplitude voltage.

From subcortical struc

preceded by epileptiform discharge with

Phenytoin applied to alumina foci in the hippo

campus was followed by decreased amplitude of voltage in abnormal dis
charges in the primary and secondary foci, or only on the treated side
when applied unilaterally.

As with phenobarbital, the effect only

lasted a few days after drug application.

Strobos and Spudis, 1960,

found that phenytoin elevated the threshold for excitation and decreased
the duration of after discharges, but did not alter the spread of dis
charges.

Guerrero-Figueroa et al. (1964) found, in contrast, that

intracerebral phenytoin blocked primary and secondary discharges, but
intraperitoneally or intramuscularly produced only slight suppression of
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epileptiform discharges.

High doses (10-40 mg/kg) facilitated dis

charges from both foci.
Phenytoin did not prevent development of focal spiking in the rat
but did reduce the discharge frequency of the focus (Musgrave, 1963).
Secondary foci developed by paroxysmal activity from these foci was less
conspicuous in phenytoin treated animals.

The effect of phenytoin on

the primary focus differed from a barbiturate effect.

Phenytoin reduced

pacemaker potentiality of old injured neurons, caused rapid repolariza
tion of elements involved in initial trauma, and suppressed subsequent
rhythmically recurring nonsynaptically induced fluctuations in neuronal
excitability.
Stark et al. (1974) found fifteen mg/kg intravenous phenytoin, to
be anticonvulsant in cats with penicillin-induced foci, but the effect
lasted only thirty minutes.

Jasper (1969) observed that phenytoin did

not raise the threhold of seizures induced by photo-stimulation or when
challenged by strychnine, and other convulsant drugs and in fact po
tentiated seizures induced by pentylenetetrazol, salicylate, and carbon
dioxide inhalation.

Phenytoin slightly elevates those seizures ini

tiated by electroshock, cortisone or thyroxin.

Phenytoin inhibits

inhibitory neurons as well as excitatory ones possibly accounting for
the increase.

Dow et al. (1973) concluded that although barbiturates

increase the number of spikes arising from the cobalt induced epileptic
foci in the rat, phenytoin has no effect.

Craig et al. (1976) also

found that phenytoin had no effect on seizure frequency, but observed
that unlike trimethadione, withdrawal of the phenytoin resulted in a
marked enhancement of seizure activity.
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The effects on seizure activity found by Craig et al. (1976), after
chronic treatment of cobalt epileptic rats with either phenytoin or
trimethadione, were not dose related.

The dose of phenytoin is very

important, because if it exceeds the effective amount and enters the
toxic range, the mechanism for arresting focal convulsive seizures might
be inhibited.

Therefore even though a low dose inhibits seizures, a

high dose may potentiate them.

High doses facilitate primary and

secondary discharges, and are likely to cause sedation, nausea, weight
loss, constipation, ataxia and nystagmus (Guerreo-Figueroa et al.,
1964).
Trimethadione (Tridione), the fourth drug used in this study, is
effective primarily in petit mal seizures.

It is the only oxazolidine-

dione used extensively in the United States today.

The chemical struc

ture is different from most of the other anticonvulsant drugs (Goodman
and Gilman, 1975).
Trimethadione in large doses produces CNS depression, analgesia,
sedation and a form of photophobia, hemeralopia (a visual disturbance
consisting of a glare or white halo around objects). The threshold for
chemical and electrically induced seizures is raised after trimethadione
administration.

It is better than phenytoin in protecting against

pentylenetetrazol-induced seizures, but not as good in modifying maximal
electroshock patterns.
Craig et al. (1976) suggested that trimethadione may enhance
spiking activity originating from the cobalt focus in rats, but limit
the subsequent spread that leads to the development of grand mal convul
sions.

Morrell et al. (1959) also observed that trimethadione depressed
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projection of seizure activity from cortical foci to the thalamus while
leaving cortical spread relatively unaffected.
phenytoin.

The opposite is true of

The thalamocortical system is very important in the genesis

of petit mal epilepsy, and the selectivity of the thalamus to trimetha
dione may account for much of its therapeutic effectiveness in this type
of epilepsy.

There is little information in the literature about this

drug in chronic animal models of epilepsy.
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MATERIALS AND METHODS

Operative Techniques

Thirty-six male albino Sprague Dawley origin, specific pathogen
free, rats from the Upjohn colony, weighing between 250 and 300 grams
each, were used in this investigation.

Twenty-four rats were in the

experimental group and had a one millimeter length of cobalt wire placed
on the surface of one cerebral hemisphere.

The other twelve rats

received glass implants of the same size as the cobalt wire, which
served as a space occupying, but non-epileptogenic lesion. The rats were
maintained on a diet of Purina Laboratory Chow and water which were
always available.
Following anesthetization with forty mg/kg sodium pentobarbital
intraperitoneally, a two centimeter midsagittal incision was made
through the shaved scalp from directly behind the eyes to between the
ears.

The periosteum was scraped aside and retracted with hemostats to

expose the skull.

The naso-frontal, coronal, lambdoidal and sagittal

sutures were located and used as coordinates to consistently place
cobalt wire or glass implants approximately three millimeters right of
the sagittal suture, and three millimeters behind the coronal suture.
two millimeter hole was drilled with a Foredom dental drill, series EE.
Figure 3 illustrates electrode placement, and headpiece construction.
Stereotaxic placement of the glass or cobalt in a precise location was
not needed because the lesion was on the cortical surface and did not
penetrate into the brain.

Adequate precision was possible by visual
23
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mapping of the skull using the highly visible sutures in the skull.
Rats weighing less than 250 grains were not used because the skull had
not completely calcified, and had a spongy, porous texture.

These small

rats hemorrhaged more frequently which made locating the sutures, and
drying the surface of the skull to adhere the cap, more difficult.

The

skull of larger rats rarely bled, and dried quickly.
A one to one-and-one half millimeter length of one millimeter dia
meter cobalt wire with oxidized metal removed by scraping, was gently
pushed through the dura and to the top of the cortical surface.

The

hole was filled with bone wax, and the skull roughened with a scalpel to
provide a more abrasive surface for the cap.

Five one millimeter holes

were drilled in the skull for placement of four recording electrodes and
one ground electrode.

One pair of holes was located one millimeter

anterior to the coronal suture and spaced three millimeters to either
side of the sagittal suture.

The next pair of holes was placed four

millimeters behind the implant site, spaced three millimeters to either
side of the sagittal suture.

A hole for the ground electrode was

drilled five millimeters in front of the coronal suture on the left side
of the sagittal suture.
Electrodes were constructed by soldering single-strand, insulated
stainless steel wire to three millimeter flat end screws.

The recording

electrodes were screwed into the holes in the skull until the head was
flush with the surface of the skull.

The tips of the screws rested

against the dural or cortical surface but did not penetrate into the
brain.

These screws were used to record the EEG, and apparently did not

disrupt normal electrical activity of the brain.

The ground electrode
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was a five millimeter pointed-end screw with deeper threading.

This was

screwed down until the head was three millimeters above the skull and
the tip was on the cortical surface, to achieve better anchorage of the
cap.

Cold-cure acrylic resin was painted thickly around the screw heads

and allowed to harden.

The hardened dental acrylic cap shielded the

wires and screws and gave the cap mechanical strength as well as helping
adhere the headpiece more firmly to the skull.

After the first ap

plication of acrylic, only the wire leads from the electrodes were
visible, projecting out of the top of the cap.

An eight-lead female

continental connector was soldered to the exposed ends of the electrode
wires.

The excess wire was tucked under the headpiece and an additional

layer of acrylic cement immobilized the wires and the headpiece.

This

procedure smoothed the sides, and lessened the danger of catching the
headpiece on the wire cages.
The animals were ready for experimental use forty-eight hours after
implanting the cobalt.

The entire operative procedure took thirty to

sixty minutes, and the headpiece was functional for as long as seven
months.

Experimental Procedure

Electroencephalogram recordings were begun no sooner than fortyeight hours after the surgery, continuing for as long as 178 days after
implant.

Wires from the male continental connector lead into a 7P511

amplifier and paper recordings were made by a Grass Model 79 polygraph.
Two hand screws on the male plug allowed the headpiece to be firmly
fitted to the female plug in the rat’s headpiece.

Two channels of EEG
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were recorded.

The montage used is shown in the inset in Figure 3.

Bipolar recordings were made at least three times with each rat after
development of the epileptic focus.
recording chamber.

A four liter beaker served as a

A cardboard box with an observation window provided

protection from environmental distraction. The rat could move freely in
the chamber restrained only by the electrode leads.

The wire leads from

the headpiece were bound in woven steel thread insulator mesh, and
brought through an opening in the top of the chamber to the Grass
polygraph.
The rats were assigned to four experimental groups with six cobalt
implanted rats, and three glass implanted rats in each group. Each group
received a different anticonvulsant drug with each rat tested at least
once at each of three dose levels.

The order in which the rat received

the dose levels was determined by a Latin square design.

The anticon

vulsant drugs tested were selected as representative of major classifi
cations of anti-convulsive drugs. The doses were chosen after reviewing
several journal articles using rat models of experimental epilepsy, and
picking frequently used low, high, and mid-range doses.

The first

experimental group received phenobarbital at 5, 10, and 20 mg/kg.
second group was given diazepam at 5, 15, and 30 mg/kg.

The

Group three got

25, 100, and 200 mg/kg phenytoin, and the fourth group received tri
methadione 40, 100, and 300 mg/kg.

All drugs were dissolved or sus

pended in physiological saline immediately before use.

The volume did

not exceed 1.5 ml and was given as a bolus injection intraperitoneally.
The EEG was recorded for forty-five minutes prior to drug admin
istration, and for three to three-and-one-half hours after. Five cobalt-
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implanted rats and two glass-implanted rats were

given sham injections

of physiological saline, and the EEG was recorded in the same fashion.

Data Evaluation

EEG recordings were examined visually by the experimenter, and were
quantified according to the number of spikes per minute, and the general
amplitude of electrical activity in microvolts. A spike and/or spike
burst was defined as an abnormally large burst of electrical activity
either appearing singly or grouped in the EEG record.

These spikes

varied in duration and voltage between subjects and between recording
sessions in one subject, but were usually consistent in appearance
within one recording session.

Electrical activity across each cortical

hemisphere of the brain was recorded, and rated separately.

No dif

ferentiation was made between spikes and spike bursts in the evaluation.
Each peak exceeding twice the EEG background electrical activity level
was counted as one unit. The number of units per minute was counted, and
an estimate of mean background amplitude was made.

These two parameters

served as a means of quantifying the EEG activity.
The data was grouped in fifteen minute blocks and then the average
number of units per minute and average microvolts of electrical activity
for the following specific time intervals were computed.
data evaluation, fifteen minute averages were further

To facilitate

grouped into five

periods, baseline was measured one hour before drug administration, and
zero to thirty, thirty to ninety, ninety to 150, and 150 to 210 minutes
after drug administration.
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Histological Examination

Brains were examined at days 11, 30, 65, 91, 142 and 178 after the
implantation of glass or cohalt in the frontal cortex.

The animals were

sacrificed by cervical dislocation, and the appropriate section of brain
immediately removed.

Tissue sections from the implanted side and the

control mirror side were fixed in Bouin's solution prior to paraffin
embedding procedures (Luna, 1968).
brain tissue were made.

Eight micron thick sections of the

Stains used were Bodian method for myelinated

and unmyelinated nerve fibers, neurofibrillae, and neuron cell bodies;
Phosphotungstic acid-Haemotoxylin (PTAH) for neural glial fibers, myelin
sheaths and collagen; Luxol Fast Blue for myelin sheaths, nuclei, and
nissl substance, and Kossa*s method for calcium salts (Luna, 1968).
Appropriate photomicrographs were taken in cooperation with The Upjohn
Company.
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RESULTS

Several parameters of the EEG tracings were evaluated to provide
means of comparing drug effects.

The frequency of spiking, measured in

peaks per minute, and the mean amplitude of electrical activity per
minute, were measured from recordings made across the implant as well as
across the contralateral hemisphere of the brain. The EEG of the glass
implanted animals was recorded and evaluated in the same way.

The mean

amplitude of the EEG and spiking rate was measured over five time in
tervals.

The first interval was thirty minutes, measured immediately

prior to the drug administration.

Thirty minutes following the injec

tion was chosen as the second interval, with the third interval covering
thirty to ninety minutes after the drug.

The fourth interval included

ninety to 150 minutes after the drug challenge.

Finally 150 to 210

minutes post-drug was^evaluated.

Evaluation of Baseline EEG Activity

Because the volume of data generated by this system of measurement
was too cumbersome to evaluate, an abbreviated method of measurement was
sought.

There was almost no difference between the implant side of the

brain and the contralateral hemisphere with respect to spiking rate or
amplitude, therefore it was not possible to demonstrate spread of the
abnormal activity from the implant side to the contralateral side.

The

first appearance of the focus was seen simultaneously in recordings from
both halves of the brain.

Because there was no difference in the effect
29
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of the four drugs studied on spiking rate or amplitude, only the implant
side will be discussed.
The presence of the abnormal epileptic activity or focus, was
clearly established within the first week after implant.

The appearance

of the abnormal EEG activity varied between rats and in one rat between
recording sessions.

Some animals exhibited a sudden burst of large

spikes, sometimes accompanied by a facial twitch or hesitation.

Some

animals had random large single spikes in the EEG, and never had spike
bursts.

Most animals did not exhibit overt behavioral seizure activity.

Some of the glass implanted controls also were observed to have an
abnormal EEG, similar in appearance, but not as severe as some of the
cobalt implanted rats.

Based upon histological confirmation, this

unexpected observation in the controls could probably be due to surgical
trauma.

Because of this trauma these animals were not considered to be

adequate controls.
The second major goal of this study was to observe spread of the
focus to the other areas of the brain.

When abnormal spiking appeared

in the area of the cortex around the lesion it appeared in the EEG
tracing on the contralateral side as well.

With the corpus callosum

intact, electrophysiological spread between the implant side and the
undamaged hemisphere took place too quickly for a general EEG recording
to differentiate.

There are therefore, no quantifiable results reported

from this objective.

The effect of anticonvulsive drugs on the focus

was evaluated on the basis of changes in spiking rate and EEG amplitude
from the pre-drug baseline.
The control animals receiving saline in place of one of the four
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anticonvulsant drugs, had variable EEG activity changes.

If the rat was

sleeping before the injection was made, the EEG tracing reflected a
change from slow wave sleep, to smaller amplitude, faster wave, alert
EEG stages.

Cobalt-implanted rats with large spike and spike-bursts

continued to show the abnormal EEG activity after the saline adminis
tration intermittently throughout the recording session.

Glass-implanted

rats in this group had no spike or spike-burst complexes, before or
after the saline injection.

Evaluation of Drug Induced Changes in the EEG

Using a nonparametric Friedman two-way analysis of variance by
ranks (Siegel, 1956), there was no significant difference at the 5%
significance level between any of the dose levels of any drug tested, so
the three dose levels have been combined, and one mean value calculated
for each drug.

Tables 1 and 2 contain the baseline EEG amplitude and

spiking rate and the percent changes in activity over the four previous
ly described time intervals.
Rats injected with phenytoin were observed to have a thirty-five
percent increase in electrical amplitude over the baseline amplitude,
from an initial level of around 166 microvolts to more than 200 microvolts
two hours after the drug (see Figure 1).

The spiking rate increased

slightly from around nineteen spikes per minute to almost twenty-one
spikes per minute, immediately after phenytoin, and after two hours was
about twenty-four spikes per minute (Table 2). A characteristic tracing
illustrating the effect of phenytoin is presented in Figure 3.
Diazepam caused an eighteen percent increase in the spiking rate
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immediately after administration, which peaked and began to recover
after ninety minutes.

During the 150-210 minute interval, the spiking

rate remained eleven and seven-tenths percent above the initial baseline
(Table 2).

Figure 2 shows the results graphically.

The amplitude of

the electrical activity rose seventeen percent over control after
diazepam (Figure 1).

After 210 minutes the amplitude was only thirteen

percent higher than the pre-drug baseline.

Figure 4 is a segment of

characteristic EEG tracing before and after diazepam administration.
Figure 5 illustrates the effect of trimethadione on the EEG of an
epileptic rat.

Trimethadione lowered the spiking rate eleven and one-

half percent in the first thirty post-drug minutes (Figure 2).

In the

following hour, the suppressed rate continued, but was only about six
percent below the pre-drug baseline.

After 150 minutes,the rate became

level at approximately fourteen spikes per minute (see Table 1).
Tridione was the only drug which lowered the mean spiking rate below the
baseline level.

Electrical amplitude increased three and four-tenths

percent in the first thirty minutes but continued to rise to a peak
increase of seventeen percent after 150 minutes.

Figure 5 illustrates

the drop in spiking rate, but increased amplitude.
The final drug tested, phenobarbital, caused a tremendous increase
in electrical amplitude of the EEG (Figure 6).

A thirty and one-half

percent increase thirty to ninety minutes after drug administration was
observed (Figure 1).

Figure 2 illustrates the almost eighty percent in

crease in spiking rate thirty to ninety minutes after the drug.

This

returned to only forty-nine percent increased over baseline after 210
minutes.

/
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Histological Results

One to two weeks after cobalt implantation a definite lesion was
present with the formation of some scar tissue.

Blood vessels were

numerous and some intracellular vacuoles were observed in the lesion
site. Figure 7 shows a phosphotungstic acid hematoxylin (PTAH) stain of
a lesion at 40X magnification eleven days after implant, showing massive
damage caused initially by the cobalt.
brain is shown in Figure 8.

The contralateral side of the

This tissue was normal, healthy, had a

moderate number of blood vessels and the nerve fibers, and pial mem
branes were intact.
Two months after the cobalt implant an increased number of blood
vessels and glial cells were observed.

In Figure 9, dark spots around

the periphery of the lesion were seen in this Luxol Blue stain.

These

resembled the secondary lesions reported by Engle (1968), and Morrell et
al. (1959).

The contralateral half of the brain was normal (Figure 10).

The glass implanted brains also had a definite lesion site, but a
less severe vascular reaction was seen than was observed after the
cobalt lesions.

Figure 11 is a 250X magnification of a glass implanted

brain, ninety-one days after implantation.

Glial cell fibers and some

vacuoles were present in the localized lesion.

In the contralateral

side of the brain shown in Figure 12, evenly spaced neurons and glial
cells were noted and no disturbance was evident.
Four months after the cobalt implant there was a marked prolifera
tion of blood vessels, glial cells, and collagen.

Fibroblasts were

present in greater number, while fewer neurons were visible in the
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lesion site.
implant.

Figure 13 shows the cobalt lesion 142 days after the

The blood vessels in the lesion were very obvious. The opaque

area near the lesion site is probably scar tissue and fluid. Figure 14
shows the normal, healthy, mirror half of the brain.

Kossa stain for

calcium salts was used to look for traces of calcium deposits near the
cobalt lesions.

The dark spots evident in the center of Figure 15 were

only slightly positive for calcium.
After six months no nerve cell fibers were evident in the area of
the cobalt lesions, but glial cell fibers were present.

Many densely

packed small cells were observed in the lesion itself.

Outside of the

immediate area of the lesion, nerve cell bodies and fibers were normal.
The tremendous infiltration of blood vessels in the lesion are shown in
Figure 16 in a 178 day old cobalt implant at 100X, stained by the Bodian
method for nerve fibers. The clear areas appear to be myelin.

Many

neurons and a moderate number of myelinated and unmyelinated nerve
fibers are present in the contralateral half of the brain (Figure 17).
Some round cells with nuclei and no nissl substance were observed.
Multi-polar neurons looked normal as did the blood supply.
The lesion site described above is shown again in Figure 18 as it
appeared stained with Luxol blue at 250X magnification.

Numerous small

vacuoles were present around blood vessels in the lesion with some
myelination easily visible in the implant areas.

There was a definite

increase in the number of glial cells in the lesion, along with membrane
ous bone fragments. The bone probably splintered from the skull during
implant.

Figure 19 shows one row of rounded cells uniform in size,

with p erm ission o f the copyright ow ner. Further reproduction prohibited w ithout perm ission

density, and cell type.
vessels are present.

The pia mater is undamaged and few blood

Neurons are evenly scattered throughout the entire

section.
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Table I
Changes in Microvolts Amplitude After
Anticonvulsant Drug Administration
______________ Diazepam_______________

Dose (n=6)
Mean baseline ±
SE (microvolts
amplitude)
Minutes
Post-Drug
0-30
30-90
90-150
150-210*

5 mg/kg

136.2112.4

15 mg/kg

30 mg/kg

140.1112.2

142.5+15.1

Mean of
Three Doses

139.61 7.2

Mean Percent Change from BaselinelSE
8.21 8.0
17.1113.5
19.1113.1
21.3114.9

3.71 3.3
11.21 6.5
9.71 9.3
-2.9121.6

12.9116.4
12.81 6.0
22.7114.5
21.3111.5

8.21
13.71
17.21
13.21

5.9
5.1
6.9
9.3

Phenytoin

Dose (n=6)

25 mg/kg

100 mg/kg

200 mg/kg

Mean of
Three Doses

Mean baseline 1
SE (microvolts
amplitude)

172.41 9.1

160.5116.0

166.3114.1

166.4119.0

Minutes
Post-Drug
0-30
30-90
90-150
150-210*

Mean Percent Change from BaselinelSE
9.61
7.31
12.41
26.51

3.1
7.9
4.9
7.7

7.31 5.6
26.8111.0
27.8112.5
46.7116.5

14.11 5.6
17.9111.1
30.91 7.5
32.61 9.1

10.31
17.31
23.71
35.31
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Table I
Changes in Microvolts Amplitude After
Anticonvulsant Drug Administration
Phenobarbital

Dose (n=6)
Mean baseline ±
SE (microvolts
amplitude)
Minutes
Post-Drug
0-30
30-90
90-150
150-210**

5 mg/kg

170.2±26.8

10 mg/kg

20 mg/kg

171.4±16.0

166.3±15.1

Mean of
Three Doses

169.3H0.3

Mean Percent Change from BaselinelSE
11.71 8.8
34.1115.6
42.0117.4
41.3122.8

1.21 7.6
17.8115.1
16.01 8.0
12.5110.1

19.71 8.4
39.5110.6
32.8110.2
22.51 5.8

10.81
30.51
28.31
25.51

4.8
7.9
7.7
8.5

Tr imethadione

Dose (n=5)

40 mg/kg

Mean baseline 1
SE (microvolts
amplitude)

157.8124.8

Minutes
Post-Drug
0-30
30-90
90-150
150-210

100 mg/kg

300 mg/kg

Mean of
Three Doses

123.0111.4

152.7+16.6

144.5110.7

Mean Percent Change from BaselinelSE
-0.11
3.01
15.21
5.81

2.7
3.7
5.5
4.1

11.41 5.4
19.81 8.3
30.2113.1
21.31 8.2

-1.021
3.6 1
4.3 1
9.5 1

5.7
6.9
4.1
7.4

3.41
8.81
17.21
12.21

*Means calculated on basis of 4 rats because of missing data.
**Means calculated on basis of 3 rats because of missing data.
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Table II
Changes in Spiking Rate After
Anticonvulsant Drug Administration
_____________ Diazepam_____________

Dose (n=6)

5 mg/kg

15 mg/kg

30 mg/kg

Mean of
Three Doses

Mean baseline ±
SE (spikes/min)

20.6± 6.3

23.9± 4.3

18.41 3.3

21.01 2.7

Minutes
Post-Drug
0-30
30-90
90-150
150-210*

Mean Percent Change from BaselinelSE
10.5±18.4
41.6±32.5
77.1±40.0
17.2±37.5

-9.9±16.5
-0.7116.6
-4.5113.8
-28.9126.2

54.7155.4
21.4121.8
40.3125.9
21.3111.5

18.4120.1
20.8114.0
27.6116.6
11.7118.4

Phenytoin

Dose (n=6)
Mean baseline 1
SE (spikes/min)
Minutes
Post-Drug
0-30
30-90
90-150
150-210**

25 mg/kg

26.8114.0

100 mg/kg

16.01 4.0

200 mg/kg

14.1+ 3.8

Mean of
Three Doses

19.0+ 4.6

Mean Percent Change from BaselinelSE
17.51 6.8
22.4117.6
38.2115.6
16.4+48.0

16.2111.5
13.7116.1
-9.2+10.4
-2.2+16.2

-6.5+ 9.6
19.1110.9
34.6+20.7
63.0+30.3

9.11 5.8
18.4+ 8.3
21.2110.2
25.7+19.6
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Table II
Changes in Spiking Rate After
Anticonvulsant Drug Administration
Phenobarbital

Dose (n=6)

5 mg/kg

Mean baseline ±
SE (spikes/min)

30.4± 7.8

Minutes
Post-Drug
0-30
30-90
90-150
150-210**

10 mg/kg

20 mg/kg

23.2+ 6.7

31.7+ 8.7

Mean of
Three Doses

28.41 4.3

Mean Percent Change from BaselinelSE
22.8± 5.9
65.7124.4
52.7124.2
50.2+17.6

-4.0+16.0
55.6+40.3
19.3120.7
38.5+48.7

39.0+20.1
115.3+39.2
99.9+19.6
58.4+37.7

18.31 9.4
78.8120.2
47.3+14.2
49.0118.7

300 mg/kg

Mean of
Three Doses

Tr imethadione

Dose (n=5)

40 mg/kg

Mean baseline ±
SE (spikes/min)

11.91 3.3

Minutes
Post-Drug
0-30
30-90
90-150
150-210

100 mg/kg

9.6+ 2.3

13.9+ 3.2

11.81 1.7

Mean Percent Change from BaselinelSE
-5.51 4.6
-5.3111.1
16.71 5.9
5.01 8.6

-13.7+ 8.9
-9.7+12.7
23.61 6.3
35.4+33.8

-15.1+19.5
-2.8114.5
20.5+17.5
8.91 9.7

-11.51 6.9
-5.91 6.9
20.2+ 6.9
16.5111.7

*Means calculated on basis of 4 rats because of missing data.
**Means calculated on basis of 3 rats because of missing data.
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Fig. 7. (Top) Cobalt implanted brain section, eleven days after im
plant. PTAH stain (40X). Lesion with vacuoles, blood vessel
proliferation and scar tissue.
Fig. 8. (Bottom) Contralateral brain hemisphere. PTAH stain (40X).
Normal tissue with meninges intact, and evenly spaced, plentiful
neurons.
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Fig. 9. (Top) Cobalt implanted brain section, sixty days after
implant, Luxol blue stain (40X). Removal of cobalt rod re
sulted in crater in lower right c o m e r of photograph.
Fig. 10.
(Bottom) Contralateral brain hemisphere, Luxol blue
stain (100X). Normal tissue.
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Fig. 11. (Top) Glass implanted brain hemisphere, ninety days after
implant. PTAH stain (250X). Extensive lesion with vacuoles,
fibers, scarring, and cellular debris.
Fig. 12. (Bottom) Contralateral brain hemisphere. PTAH stain (250X).
Normal tissue with nerve fibers, glial cells, and blood vessels.
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Fig. 13. (Top) Cobalt implanted brain section, 142 days after im
plant. PTAH stain (40X). Massive disruption of normal
cortical structure.
Fig. 14. (Bottom) Contralateral brain hemisphere.

PTAH stain (40X)

Normal tissue.
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Fig. 15. Cobalt implanted brain section, 142 days after implant.
Kossa's stain for calcium (40X).
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Fig. 16. (Top) Cobalt implanted brain section, 178 days after im
plant. Bodian stain for nerve fibers (100X). Lesion in center,
normal tissue at periphery. Cellular debris and increased vas
cularity in lesion site.
Fig. 17. (Bottom) Contralateral brain hemisphere. Bodian stain for
nerve fibers (100X). Many nerve cells and fibers, normal blood
supply, and pia mater intact.
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Fig. 18. (Top) Cobalt implanted brain section, 178 days after im
plant. Luxol blue stain (250X). Numerous intracellular vac
uoles, necrosis, and cellular debris are evident.
Fig. 19. (Bottom) Contralateral brain hemisphere. Luxol blue
stain (250X). Pia mater intact, evenly scattered neurons, few
blood vessels are seen throughout the cortex.
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DISCUSSION

The cobalt model of experimental epilepsy is widely accepted as an
Investigational tool for studying focal epilepsy (Van Duijn and Visser,
1972).

Development of a primary epileptic foci was evident within the

first week after cobalt implant, which confirmed the observations of
Henjyoyi and Dow (1965).
A delay between implant and development of electrical abnormality,
described by Dow et al.

(1972), was not observed.

EEG recordings were

not made until at least three days after cobalt implant to insure ade
quate recovery from surgery, and a delay may have been missed.

Little

decrease in activity three months after implant was observed, contrary
to reported attenuation after scar formation in studies in rat frontal
cortex (Dow et al., 1972).

Active epileptogenic foci were observed in

some rats in this study five months after cobalt implant.
The presence of an independent mirror focus or a secondary epi
leptogenic lesion was not established.
al.

(1972).

This confirmed work by Dow et

The contralateral cortex was not histologically abnormal up

to six months after cobalt implantation.

Some instances of spike bursts

occurred on the hemisphere of the brain contralateral to the cobalt
implant.

In other EEG recordings, abnormal spike bursts were observed

in both sides of the brain, but were not synchronized.

Those few EEG

tracings are not in themselves conclusive evidence of a mirror focus.
Certain idiosyncracies of the cobalt model should be acknowledged
when interpreting results of these studies.

Most cobalt implanted rats

did have unequivocal electrical evidence of abnormal discharges in the
53
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cortical region surrounding the lesion. Few rats had any overt behav
ioral twitches or seizures.

In animals with observable seizures, the

EEG spiking was always in distinct rhythmic spike bursts.

These seiz

ures consisted of whisker twitches, forelimb jerks, or head nodding, all
more pronounced on one side of the rat.

Some of the glass-implanted

rats also developed abnormal cortical discharges, similar in appearance
to the cobalt induced spike bursts.

Histological examination of the

glass-implanted brains, suggested that the abnormal discharges could
have been initiated by surgical trauma or scar formation adjacent to the
glass implant.

The presence of a large necrotic lesion in the glass

controls is in contrast to results reported by Dow et al. (1972). These
non-cobalt electrical foci usually disappeared more quickly than the
cobalt-induced foci, although the lesion remained.
Another problem in data interpretation arose from the difficulty in
defining a spike.

No absolute system has been accepted for differen

tiating a single spike from a spike burst.

In this study, where it was

possible, each individual peak of EEG tracing was counted as a spike if
it exceeded twice the background level of electrical amplitude.

This

flexible definition of spiking took into account the baseline of ac
tivity for each individual subject, and changes in the baseline in
fluenced by non-epileptic parameters such as sleep stages.
is in agreement with Roldan et al.

This study

(1971), that in EEG tracings with

sleep cycles evident, it was difficult to differentiate between a sleep
spindle and a spike burst.

In tracings with more than 350 microvolts of

electrical amplitude, the spikes are obscured by high voltage, fast or
slow electrical activity, which could be seizure, drug, or sleep in-
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duced, or a combination of all three.

This confusion over drug induced

spiking opposed to cobalt-focus induced spiking was discussed by Dow et
al.

(1973), and Roldan et al. (1971).

Swisher (1962) proposed that some

of the atypical rat EEG patterns could be due to activated sleep, also
called paradoxical sleep.

These fast, low voltage six to eight hertz

waves are theorized to be part of the normal sleep-wakefulness cycle of
many animals.
The four anticonvulsant drugs tested in this study were repre
sentative of four major types of anticonvulsants, the benzodiazepines,
oxazolidinediones, barbiturates, and hydantoins.

This cross-selection

was chosen in an attempt to show differences in drug effects on the
cobalt epileptogenic focus.

This portion of the study was not suc

cessful, due to the high degree of variability between animals.

No

significant differences were found between any drug or any dose, on
either spiking rate or electrical amplitude with Friedman’s nonparametric two-way analysis of variance (Siegel, 1956).

Several studies

have reported similar large variation, and only limited dose relation
ships (Stark et al., 1974; Kutt et al., 1968; Louis et al., 1968).
Edmonds et al. (1974) found phenytoin, phenobarbital and diazepam to be
relatively ineffective against penicillin-induced foci.

This work

produced similar conclusions, with the addition of trimethadione as a
virtually ineffective anticonvulsant on cobalt-induced epilepsy.

These

results are in contrast with Louis et al. (1968), Sharer et al. (1971),
Roldan et al. (1971), and Stark et al. (1974) who all reported some
degree of anticonvulsant activity in one or all of the four compounds in
chronic animal models of epilepsy.
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Phenobarbital caused the greatest increase in spiking rate of any
of the anticonvulsant drugs tested.

Ninety minutes after intraperi-

toneal administration the spiking rate had increased almost
percent over the pre-drug baseline.

eighty

The electrical amplitude had

increased thirty percent, ninety minutes after phenobarbital.

Marked

sedation was observed in all of the rats, especially at the highest dose
tested.

Since this tremendous increase in focus activity was also seen

in the glass implanted controls, the increases probably reflected an in
crease in high amplitude, slow wave sleep with sleep spindles, rather
than increased epileptic discharge frequency or amplitude. Chocholova et
al. (1970), Dow et al. (1973), and Morrell et al. (1959), reported
increased incidence of epileptiform spiking after barbiturates, but also
postulated the increases were due to slow wave sleep or toxicity.
Ectors (1955) and Millichap (1969) found a suppression of focal cortical
epileptic discharges, which was not confirmed in this study.

Edmonds et

al. (1974) found no marked charge in spiking rate after 15 or 30 mg/kg
phenobarbital, orally, in penicillin-induced epileptic rats.
reported that the higher dose was toxic.

He also

The EEG spiking rate and

increased amplitude dropped slightly from the ninety minute peak, but
was still elevated fifty percent over the baseline spiking rate and
twenty-five percent over the baseline amplitude after 210 minutes post
drug.
The only anticonvulsant drug tested which had a greater percent
increase in EEG electrical amplitude than phenobarbital, was phenytoin.
Phenytoin produced a continuous rise in amplitude which had not peaked
after 210 minutes post-drug.

This thirty-five percent increase was
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larger than the maximum twenty-five percent phenobarbital induced
percent change.

This prolonged increase could be indicative of a longer

latent period before the effect of the drug is evident, or a longer
duration of action of the drug, possibly due to a slower metabolism.
The spiking frequency also increased, although unlike the phenobarbital
effect, only a twenty-five percent change, comparable to the percent
change of amplitude, was observed.

This relatively mild change in

spiking rate confirms results of Edmonds et al. (1974), Craig et al.
(1976), and Dow et al. (1975).

The observations of Van Duijn and Visser

(1972), and Stark et al. (1974), that phenytoin was anticonvulsant after
fifteen mg/kg intravenous in the cat, was not confirmed.

The effect of

phenytoin on the EEG amplitude most closely resembled that of pheno
barbital whereas the effect on the spiking rate was similar to diazepam.
Trimethadione produced an immediate eleven and one-half percent
decrease from baseline in mean spiking rate.

This was the only anti

convulsant tested which consistently decreased the spiking rate for
ninety minutes after drug administration.

After 150 minutes, the

spiking rate had increased twenty percent over the baseline rate where
it leveled.

This second phase increase was similar to an enhancement of

spiking activity observed by Craig et al. (1976) in cobalt-epileptic
rats. Unlike the other drugs tested, very little sedation was observed
even at the high dose.

The effect of trimethadione on the EEG amplitude

closely resembled diazepam.

Goth (1976) postulated that diazepam and

trimethadione exert an effect primarily on potassium permeability in
neurons, whereas phenytoin influences sodium permeability.

Drugs ef

fective in the treatment of petit mal tend to decrease potassium perme
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ability.
Diazepam produced slight increases in spiking rate and amplitude
which peaked at 150 minutes and returned to only about 12 percent
greater than baseline activity level.

This increase confirms data

presented by Edmonds et al. (1974) who found that at 30 mg/kg diazepam
induced a variable increase in spiking frequency.

This is in contrast

to anticonvulsant activity reported by Stark et al.

(1974), with 0.5

mg/kg and 1 mg/kg in penicillin epileptic cats, and by Edmonds et al.
(1974) with 15 mg/kg in penicillin epileptic rats. Bell (1970) and
Camerman and Camerman (1970) observed low voltage, delta fast waves in
the EEG tracings after diazepam.

This may be similar to the activated,

or paroxysmal sleep discussed by Swisher (1962).

Stretches of low

voltage fast waves were occasionally observed after diazepam, but not
enough for conclusive evidence of altered EEG activity.
Presence of calcium deposits in the lesion site, that was exten
sively discussed in the literature, were confirmed.

The calcium pre

cipitate observed, however, was not as intense as that observed by Payan
(1971).

Myelin was observed in the lesion site after six months which

agrees with Payan*s description of myelin present three months after
cobalt implant.

Presence of edema, inflammatory cell infiltration,

necrosis, and fibrous scarring also confirmed histological changes
previously discussed in the literature review.

Lesions in the glass

implanted animals probably resulted from surgical trauma and infection
precipitated by the non-sterile, sharp edged glass. Large lesions were
evident soon after cobalt implant, but no correlation between lesion
size and magnitude of electrical discharges was seen, which is com
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patible with observations made by Engle (1968). The depression in the
cortical surface was littered with mineral deposits, bone splinters and
inflammatory cells, and was also necrotic. This was in contrast to
Engle’s description of an empty crater left by the cobalt rod.
The dark spots observed at the periphery of the lesion in some of
the two months, cobalt-implanted brains, resembled the secondary lesions
reported by Engle (1968) and Morrell et al. (1959).

Much additional

investigation is needed before this observation can be attributed to
anything other than artifacts in preparation of the stained tissue
section.

Another possible explanation could be that a branch of the

primary lesion was jutting out into the adjacent undisturbed cortex,
possibly with subcortical connections.
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CONCLUSIONS

A chronic, long-lasting, epileptogenic lesion was created by
implanting cobalt on the cortex of rat brains.

Few of the seizures were

accompanied by behavioral manifestations such as muscle jerks or whisker
twitches.

However, electrical evidence of abnormalities in the EEG in

the form of either spikes or spike bursts were evident.
Trimethadione was the only anticonvulsant drug tested which lowered
the spiking rate.

Phenytoin, diazepam, and phenobarbital caused in

creases in the number of spikes or spike bursts.

Administration of all

four compounds resulted in an increase in EEG microvolts amplitude. This
probably reflected an increase in drug-induced high amplitude, slow wave
sleep, or drowsiness, rather than activation of the epileptic focus.
Although the decreased spiking rate after trimethadione was temporary,
this drug has been shown to be the most successful in reducing cobaltinduced EEG abnormalities without producing drowsiness or sleep.
Large lesions were detected histologically in both the cobalt and
glass implanted animals.

Presence of edema, inflammatory cell infil

tration necrosis, scarring, neuronal degeneration, and calcium pre
cipitate at the site of the cobalt lesions were observed.

Where lesions

occurred in glass implanted animals, they were shown to be due to surg
ical trauma and infections resulting from non-sterile implants.
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